Back

Select your region

Arrange a consultation about stem cells

Learn more

List of life saving
transplantations

List of uses for stem cells approved by the FamiCord Group’s laboratories:

Image
List of uses for stem cells approved by the FamiCord Group’s laboratories:
Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
701 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 57,2
702 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,1
703 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,4
704 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 2,8
705 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5,9
706 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 11,9
707 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 54,2
708 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 78,4
709 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
710 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 58,2
711 Cord Tissue Autologous Autism Neurology 2025 Experimental Therapy Romania 5
712 Cord Tissue Allogeneic – Related Autism Neurology 2025 Experimental Therapy Romania 5
713 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 4,1
714 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 7,9
715 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,8
716 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 25,8
717 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
718 Cord Tissue Allogeneic – Unrelated Progressive bulbar palsy Neurology 2025 Experimental Therapy Poland 62,3
719 Cord Tissue Allogeneic – Unrelated Encephalopathy Neurology 2025 Experimental Therapy Poland 67,2
720 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,8
721 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 61,9
722 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5,11
723 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
724 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,5
725 Cord Tissue Allogeneic – Unrelated Myelitis Neurology 2025 Experimental Therapy Poland 38,8
726 Cord Tissue Allogeneic – Unrelated Anemia Neurology 2025 Experimental Therapy Poland 3,2
727 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
728 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,1
729 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2025 Experimental Therapy Poland 5,1
730 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,2
731 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,1
732 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5,11
733 Cord Tissue Allogeneic – Unrelated Progressive bulbar palsy Neurology 2025 Experimental Therapy Poland 63
734 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 15,2
735 Cord Tissue Allogeneic – Unrelated GvHD Immunology 2025 Experimental Therapy Poland 13
736 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 48,2
737 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 51,6
738 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2025 Experimental Therapy Poland 12,9
739 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 10,1
740 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 8,4
741 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,7
742 Cord Tissue Allogeneic – Unrelated Cerebral Infarction Neurology 2025 Experimental Therapy Poland 57,8
743 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,7
744 Cord Tissue Allogeneic – Unrelated Cerebellar Syndrome Neurology 2025 Experimental Therapy Poland 43,4
745 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 61,1
746 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 57,9
747 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,2
748 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 7,1
749 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 3
750 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2025 Standard Therapy Turkey 5,9
751 Cord Blood Autologous Aplastic Anemia Hematology 2025 Standard Therapy Poland 2
752 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2025 Standard Therapy Turkey 6,8
753 Cord Blood Allogeneic – Related Cerebral Palsy Neurology 2025 Experimental Therapy Portugal 1 year and 8 months
754 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Romania 5
755 Cord Blood Allogeneic Acute lymphoblastic leukemia Hematology 2025 Standard Therapy Poland 13
756 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5 ,5
757 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 7,2
758 Cord Blood Allogeneic Thalassemia Major Hematology 2025 Standard Therapy Turkey 10,9
759 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 4,1
760 Cord Blood Autologous Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,1
761 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,2
762 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 2,11
763 Cord Blood Autologous Unbalanced AVSD Cardiovascular 2025 Experimental Therapy Poland 5 months
764 Cord Blood Allogeneic – Related Relapsed Lymphoblastic Leukemia Hematology 2025 Standard Therapy Turkey 8,5
765 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 10,1
766 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,7
767 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 4,4
768 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,5
769 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5,4
770 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 3,9
771 Cord Blood Allogeneic – Related D57.1 Sickle Cell Anemia Hematology 2025 Standard Therapy Turkey 5 years 6 months
772 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 66
773 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
774 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Poland 71
775 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 72
776 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 47
777 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Ukraine 43
778 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 49
779 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 51
780 Bone Marrow Family Allogeneic Philadelphia – positive Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 61
781 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 58
782 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy NETHERLANDS 63
783 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 65
784 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy France 63
785 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 68
786 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy France 71
787 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russia 51
788 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 62
789 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 54
790 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 16
791 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 61
792 Bone Marrow Family Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy Poland 61
793 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 70
794 Bone Marrow Family Allogeneic PostET Myelofibrosis Hematology 2025 Standard Therapy Netherlands 21
795 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 68
796 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia/ Mielodysplastic Syndrome Hematology 2025 Standard Therapy Germany 65
797 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 60
798 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 33
799 Bone Marrow Family Allogeneic Muscular Dystrophy Association Hematology 2025 Standard Therapy United Kingdom 75
800 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 72